These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 993344)

  • 1. Human myeloma IgA half-molecules.
    Spiegelberg HL; Fishkin BG
    J Clin Invest; 1976 Nov; 58(5):1259-65. PubMed ID: 993344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical study of a human myeloma IgG1 half molecule.
    Seligmann M; Mihaesco E; Chevalier A; Miglierina R
    Ann Immunol (Paris); 1978; 129 C(6):855-70. PubMed ID: 85430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA1 half molecules in human multiple myeloma and the in vitro production of similar fragments from intact IgA1 molecules.
    Biewenga J; Van Loghem E
    Clin Exp Immunol; 1983 Feb; 51(2):395-400. PubMed ID: 6839548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human myeloma IgG half-molecules. Structural and antigenic analyses,
    Spiegelberg HL; Heath VC; Lang JE
    Biochemistry; 1975 May; 14(10):2157-63. PubMed ID: 50083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA half molecules. II. Genetic variants of IgA detected in normal mouse intestinal contents.
    Mushinski JF; Dungan MM
    J Immunol; 1976 Nov; 117(5 Pt 1):1668-75. PubMed ID: 826592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human IgA1 half-molecules: clinical and immunologic features in a patient with multiple myeloma.
    Sakurabayashi I; Kin K; Kawai T
    Blood; 1979 Feb; 53(2):269-78. PubMed ID: 367466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and quantification of half-molecule immunoglobulins.
    Kawai T; Sakurabayashi I
    Ann Acad Med Singap; 1980 Jan; 9(1):50-3. PubMed ID: 6778364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and association of heavy and light chain variable region subgroups among human IgA immunoglobulins.
    Capra JD; Kehoe JM
    J Immunol; 1975 Feb; 114(2 Pt 1):678-81. PubMed ID: 804511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bence Jones proteins and light chains of immunoglobulins. XI. A transient Bence Jones-related protein associated with corticosteroid therapy.
    Solomon A; McLaughlin CL; Capra JD
    J Clin Invest; 1975 Mar; 55(3):579-86. PubMed ID: 803979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of pepsin fragments of human IgA1 to determine domain-specificity of monoclonal anti-IgA antibodies.
    Biewenga J; Faber A; Pronk JC; Haaijman JJ
    Immunology; 1986 Sep; 59(1):153-8. PubMed ID: 3093370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential susceptibility of human IgA immunoglobulins to streptococcal IgA protease.
    Plaut AG; Wistar R; Capra JD
    J Clin Invest; 1974 Dec; 54(6):1295-300. PubMed ID: 4436434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size heterogeneity of human IgA myeloma proteins. Relationships between polymers and "J" chain.
    Fine JM; Lambin P; Frommel D
    Biomedicine; 1973 Mar; 18(2):145-51. PubMed ID: 4199987
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of an antiserum specific for the Fabalpha fragment. Its use for detection of alpha-heavy chain disease protein by immunoselection.
    Doe WF; Spiegelberg HL
    J Immunol; 1979 Jan; 122(1):19-23. PubMed ID: 762416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical studies on heterogeneity of IgD myeloma proteins.
    Ohtani H; Sakaguchi K; Saito M
    Immunology; 1981 Aug; 43(4):717-22. PubMed ID: 6168563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological classification of 31 multiple myeloma patients.
    Qiu WX; Huang NH; Wu GH
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(2):79-83. PubMed ID: 2123037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of IgA2-lambda type M-protein that IgA concentration differs from the values of M-protein by serum protein electrophoresis].
    Fukushima M; Sugano M; Ichikawa T; Honda T; Totsuka M; Katsuyama T; Fujita K
    Rinsho Byori; 2001 Jul; 49(7):690-4. PubMed ID: 11519133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of IgA myeloma proteins isolated rom sera of patients with the hyperviscosity syndrome.
    Mestecky J; Hammack WJ; Kulhavy R; Wright GP; Tomana M
    J Lab Clin Med; 1977 May; 89(5):919-27. PubMed ID: 404374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycopeptides of heavy chains from human IgA myeloma proteins.
    Despont JP; Abel CA
    J Immunol; 1974 May; 112(5):1623-7. PubMed ID: 4594412
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and some properties of rat secretory component.
    Vaerman JP; Heremans JF; Bazin H; Beckers A
    J Immunol; 1975 Jan; 114(1 Pt 2):265-9. PubMed ID: 803998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential susceptibility of rabbit sIgA subclasses to trypsin cleavage: characterization of the fragments obtained from the g subclass.
    Tseng J; Knight KL
    J Immunol; 1975 Aug; 115(2):454-61. PubMed ID: 807638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.